Abstract
Pulmonary embolism (PE) most often occurs in the setting of lower extremity deep venous thrombosis (DVT) and is a major contributor to morbidity and mortality worldwide. First-line therapy is systemic anticoagulation (AC), but some patients have contraindications. Additionally, treatment may be ineffective at PE prevention or result in undesirable side effects such as spontaneous bleeding. In these patients, inferior vena cava (IVC) filters can be placed to provide mechanical clot filtration to prevent PE in the setting of DVT. First introduced in the 1960s, IVC filters have evolved into low-profile devices, which can be deployed percutaneously. A variety of models are available on the market today, including permanent and optional (retrievable) devices, the latter allowing for retrieval once the period of venothromboembolism (VTE) risk has elapsed. Standard technique for IVC filter retrieval includes the use of endovascular snares; however alternative methods such as endobronchial forceps or laser sheath ablation may be needed in complicated cases. Studies have shown the efficacy of IVC filters for reducing the risk of recurrent symptomatic PE but have also revealed an increased risk for DVT. There has also been increasing recognition of device-related complications, including filter migration, fracture, and penetration through the IVC wall, which can lead to significant clinical sequelae. Consequently, it is essential to place IVC filters in appropriately selected patients and provide vigilant follow-up to remove the filters as soon as clinically indicated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12:464–74.
Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38:S495–501.
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149:315–52.
Mobin-Uddin K, Callard GM, Bolooki H, Rubinson R, Michie D, Jude JR. Transvenous caval interruption with umbrella filter. N Engl J Med. 1972;286:55–8.
Wingerd M, Bernhard VM, Maddison F, Towne JB. Comparison of caval filters in the management of venous thromboembolism. Arch Surg. 1978;113:1264–71.
Greenfield LJ, Zocco J, Wilk J, Schroeder TM, Elkins RC. Clinical experience with the Kim-ray greenfield vena caval filter. Ann Surg. 1977;185:692–8.
Johnson MS, Nemcek AA Jr, Benenati JF, Baumann DS, Dolmatch BL, Kaufman JA, et al. The safety and effectiveness of the retrievable option inferior vena cava filter: a United States prospective multicenter clinical study. J Vasc Interv Radiol. 2010;21:1173–84.
Le Blanche AF, Ricco JB, Bonneau M, Reynaud P. The optional VenaTech() convertible () vena cava filter: experimental study in sheep. Cardiovasc Intervent Radiol. 2012;35:1181–7.
Lyon SM, Riojas GE, Uberoi R, Patel J, Lipp ME, Plant GR, et al. Short- and long-term retrievability of the Celect vena cava filter: results from a multi-institutional registry. J Vasc Interv Radiol. 2009;20:1441–8.
Smouse HB, Rosenthal D, Thuong VH, Knox MF, Dixon RG, Voorhees WD 3rd, et al. Long-term retrieval success rate profile for the Gunther Tulip vena cava filter. J Vasc Interv Radiol. 2009;20:871–7. quiz 8
Stavropoulos SW, Chen JX, Sing RF, Elmasri F, Silver MJ, Powell A, et al. Analysis of the final DENALI trial data: a prospective, multicenter study of the Denali inferior vena cava filter. J Vasc Interv Radiol. 2016;27:1531–8. e1
Ziegler JW, Dietrich GJ, Cohen SA, Sterling K, Duncan J, Samotowka M. Proof trial: protection from pulmonary embolism with the OptEase filter. J Vasc Interv Radiol. 2008;19:1165–70.
Mismetti P, Rivron-Guillot K, Quenet S, Décousus H, Laporte S, Epinat M, et al. A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest. 2007;131:223–9.
Caplin DM, Nikolic B, Kalva SP, Ganguli S, Saad WE, Zuckerman DA, Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol. 2011;22:1499–506.
Stein PD, Matta F, Hull RD. Increasing use of vena cava filters for prevention of pulmonary embolism. Am J Med. 2011;124:655–61.
Angel LF, Tapson V, Galgon RE, Restrepo MI, Kaufman J. Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol. 2011;22:1522–30. e3
Vijay K, Hughes JA, Burdette AS, Scorza LB, Singh H, Waybill PN, et al. Fractured bard recovery, G2, and G2 express inferior vena cava filters: incidence, clinical consequences, and outcomes of removal attempts. J Vasc Interv Radiol. 2012;23:188–94.
Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998;338:409–15.
Group PS. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (prevention du Risque d'Embolie Pulmonaire par interruption cave) randomized study. Circulation. 2005;112:416–22.
Mismetti P, Laporte S, Pellerin O, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA. 2015;313:1627–35.
White RH, Brunson A, Romano PS, Li Z, Wun T. Outcomes after vena cava filter use in noncancer patients with acute venous thromboembolism: a population-based study. Circulation. 2016;133:2018–29.
Andreoli JM, Lewandowski RJ, Vogelzang RL, Ryu RK. Comparison of complication rates associated with permanent and retrievable inferior vena cava filters: a review of the MAUDE database. J Vasc Interv Radiol. 2014;25:1181–5.
US Food and Drug Administration: Inferior vena cava (IVC) filters: initial communication. Risk of adverse events with long term use. 2010.
US Food and Drug Administration: Removing retrievable inferior vena cava filters: FDA safety Communication. 2014.
Sarosiek S, Crowther M, Sloan JM. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med. 2013;173:513–7.
Karp JK, Desai KR, Salem R, Ryu RK, Lewandowski RJA. Dedicated inferior vena cava filter service line: How to optimize your practice. Semin Interv Radiol. 2016;33:105–8.
Winters JP, Morris CS, Holmes CE, et al. A multidisciplinary quality improvement program increases the inferior vena cava filter retrieval rate. Vasc Med. 2016;22:51–6.
Ray CE Jr, Mitchell E, Zipser S, Kao EY, Brown CF, Moneta GL. Outcomes with retrievable inferior vena cava filters: A multicenter study. J Vasc Interv Radiol. 2006;17:1595–604.
Iliescu B, Haskal ZJ. Advanced techniques for removal of retrievable inferior vena cava filters. Cardiovasc Intervent Radiol. 2012;35:741–50.
Stavropoulos SW, Ge BH, Mondschein JI, Shlansky-Goldberg RD, Sudheendra D, Trerotola SO. Retrieval of tip-embedded inferior vena cava filters by using the endobronchial forceps technique: Experience at a single institution. Radiology. 2015;275:900–7.
Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Excimer laser-assisted removal of embedded inferior vena cava filters: A single-center prospective study. Circulation Cardiovascular Interventions. 2013;6:560–6.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Chen, J., Stavropoulos, S.W. (2018). IVC Filters. In: Keefe, N., Haskal, Z., Park, A., Angle, J. (eds) IR Playbook. Springer, Cham. https://doi.org/10.1007/978-3-319-71300-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-71300-7_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-71299-4
Online ISBN: 978-3-319-71300-7
eBook Packages: MedicineMedicine (R0)